Adenovirus-mediated MUC1 gene transduction into human blood-derived dendritic cells

Journal of Immunotherapy

Volumn 24, Issue 4, 2001, Pages 345-353

  Maruyama, K ^a   Akiyama, Y ^a   Nara Ashizawa, N ^a   Hojo, T ^a   Cheng, J ^a   Mizuguchi, H ^a   Hayakawa, T ^a   Yamaguchi, K ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Adenovirus vector; Cytotoxic T lymphocyte; Human blood DC; Mixed leukocyte reaction; MUC1

Indexed keywords

CD8 ANTIGEN; COMPLEMENTARY DNA; GENE PRODUCT; HLA ANTIGEN CLASS 1; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MUCIN 1; PADHM4 MUC1; PLASMID VECTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENE STRUCTURE; GENE TARGETING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CA-15-3 ANTIGEN; COS CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; GENE EXPRESSION; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034856787     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200107000-00010     Document Type: Article

References (44)

1. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity
2. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ
3. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
4. Murine dendritic cells pulsed with whole tumor lysate mediate potent antitumor immune responses in vitro and in vivo
5. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
6. Cloning and sequencing of a human pancreatic tumor mucin cDNA
7. Mucin-type glycoproteins
8. Mucins: Structure, function, and association with malignancy
9. Expression of MUC apomucins in normal pancreas and pancreatic tumors
10. Stuck in the MUC on the long and winding road
11. Comparison of O -linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines
12. Cloning of a human UDPN-acetyl-α-D-galactosamine: Polypeptide N-acetylgalactosminyltransferase that complements other GalNAc-transferase in complete O-glycosylation of the MUC1 tandem repeat
13. Cytotoxic T lymphocytes from human with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site
14. Enhancement of reactivity of anti-MUC1 core protein antibody and killing activity of anti-MUC1 cytotoxic T cells by deglycosylation of target tissue or cells
15. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation
16. Identification of an HLAA11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin
17. + T cells
18. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells
19. Induction of HLAunrestricted and HLA-class-II-restricted cytotoxic T lymphocytes against MUC-1 from patients with colorectal carcinoma using recombinant MUC-1 vaccinia virus
20. Specific, major histocompatibility complex-unrestricted recognition of tumorassociated mucins by human cytotoxic T cells
21. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein
22. Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses
23. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2
24. Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells
25. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method
26. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors
27. Recombinant epithelial cell mucin (MUC1) expressed in baculovirus resembles antigenically tumor associated mucin, target for cancer immunotherapy
28. Therapeutic serum concentrations of human alpha 1-antitrypsin after adenoviralmediated gene transfer into mouse hepatocytes
29. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte-macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
30. The multi-epitope approach for immunotherapy for cancer: Identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors
31. Presentation of MUC1 tumor antigen by class 1 MHC and CTL function correlate with the glycosylation state of the protein taken up by dendritic cells
32. The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells
33. Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice
34. Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model
35. Immunity to murine breast cancer cells modified to express MUC1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1
36. Murine immune response to cells transfected with human MUC1: Immunization with cellular and synthetic antigens
37. Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells
38. Chimpanzee dendritic cells derived in vitro from blood monocytes and pulsed with antigen elicit specific immune responses in vivo
39. A comparison of gene transfer methods in human dendritic cells
40. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
41. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation
42. Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro
43. Human dendritic cells genetically engineered express high levels of the human epithelial tumor antigen mucin (MUC-1)
44. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells